Watch “The FDA's Role in Gene Therapy,” from ASGCT and NORD

The third in a series of five educational webinars from ASGCT and the National Organization for Rare Disorders (NORD), is now available to watch for free.

Download the Slides Here

This session, held on Oct. 30, explores regulatory pathways for gene therapies, how gene therapies are deemed safe, and more. Speakers include Peter Marks, M.D., Ph.D., director of the FDA's Center for Biologics Evaluation and Research (CBER); and Julie Tierney, J.D., senior policy advisory for strategic planning and legislation at CBER. To learn more about the FDA's role in the process of developing gene therapies, visit our Patient Education portal.

Mark your calendar for the rest of the sessions in this free webinar series. All the webinars are designed to inform patients, patient advocates, families, and the public about various aspects of gene therapy.

• Understanding the Gene Therapy Process and Aftercare – Wednesday, November 20
• Life After Gene Therapy – Wednesday, December 18

If you missed the first two webinars, you can watch “Gene Therapy: Yesterday, Today and Tomorrow” here, and "The Science Behind Gene Therapy" here. 

Related Articles